Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

8.6%

3 terminated/withdrawn out of 35 trials

Success Rate

76.9%

-9.6% vs industry average

Late-Stage Pipeline

11%

4 trials in Phase 3/4

Results Transparency

20%

2 of 10 completed trials have results

Key Signals

7 recruiting2 with results

Enrollment Performance

Analytics

N/A
11(68.8%)
Phase 4
2(12.5%)
Phase 3
2(12.5%)
Phase 1
1(6.3%)
16Total
N/A(11)
Phase 4(2)
Phase 3(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (35)

Showing 20 of 35 trials
NCT07412886Not ApplicableNot Yet Recruiting

Advanced MRI in IVH

Role: collaborator

NCT07350395Recruiting

Exploring and Measuring the Impact of Steroids in Children and Young People

Role: collaborator

NCT06731855Recruiting

An Exploratory Physiological Study of Post-operative Recovery in Surgical Neonates and Dimethylarginine:Arginine Levels

Role: collaborator

NCT07183579Recruiting

Effective Dosing of Burosumab in XLH

Role: collaborator

NCT07112794Not Yet Recruiting

Calprotectin and Gut Disease Study

Role: collaborator

NCT03816397Phase 4Completed

Adalimumab in JIA-associated Uveitis Stopping Trial

Role: collaborator

NCT06291142Completed

Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot

Role: collaborator

NCT06167928Recruiting

Developing Allogeneic Musculoskeletal Therapies

Role: collaborator

NCT04629157Not ApplicableCompleted

The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19

Role: lead

NCT06590142Recruiting

Hirschsprung's Advances; Working Towards Autologous tIssue therapIes

Role: lead

NCT06592534Not Yet Recruiting

Babies With Enterocolitis - A Study of Faecal Calprotectin in Hirschsprung Disease (The BEACH Study)

Role: lead

NCT02871089Not ApplicableActive Not Recruiting

Closed Loop From Onset in Type 1 Diabetes

Role: collaborator

NCT05469711Not ApplicableCompleted

PlayPhysio: Making Physio Fun

Role: lead

NCT02832050Not ApplicableWithdrawn

PLAY Therapy Intervention: Re-Modelling Patient Experience (The PLAYTIME Study)

Role: lead

NCT05450991Recruiting

Long-term Qualitative and Quantitative Outcomes of Children With Hirschsprung's Disease and Anorectal Malformations

Role: lead

NCT03170622Completed

Evaluation of Faecal Volatile Organic Compounds in the Diagnosis of Paediatric Inflammatory Bowel Disease

Role: lead

NCT05986045Not Yet Recruiting

ENHANCE- Establishing Natural History in an Advanced New CF Care Era

Role: collaborator

NCT05867745Unknown

The National Transition Evaluation Study

Role: collaborator

NCT04759144Not ApplicableCompleted

FASter Insulin in Closed-loop Technology in Children

Role: collaborator

NCT05614427Not ApplicableCompleted

The LAVA (Lateral Flow Antigen Validation and Applicability) 2 Study for COVID-19

Role: lead